Buy Celrixafor: A Generic Version of Mozobil from India
-
Celrixafor (Plerixafor) is 0.24 mg/kg body weight administered by subcutaneous (SC) injection. Use the patient’s actual body weight to calculate the volume of Celrixafor to be administered. Celrixafor solution for subcutaneous injection is approved by the FDA to be used along with granulocyte-colony stimulating factor (G-CSF) in order to mobilize the hematopoietic stem cells to the peripheral blood for gathering and subsequent autologous transplantation in non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) patients.